Indo Rama Synthetics Q2 FY27 Earnings Call Transcript Released
Indo Rama Synthetics released its Q2 FY27 earnings call transcript. The company reported a 10% YoY increase in Q2 revenue to ₹1,344 crore and a 201.8% rise in profit after tax to ₹74.1 crore. For H1 FY27, PAT grew 78.3% to ₹137.8 crore. A new ₹200 crore specialty expansion is planned, targeting 15% revenue and 20% EBITDA growth.
The earnings call transcript reveals robust financial performance and a significant new investment plan for specialty products, which is expected to drive substantial growth in revenue and EBITDA. This indicates a material positive development for the company.
The company reported strong financial results with significant growth in profit after tax and EBITDA, alongside a reduction in debt and improved cash flow. The planned expansion also indicates a positive future outlook.
Indo Rama Synthetics (India) Limited has submitted the transcript of its Q2 FY27 earnings conference call, which was held on Monday, October 26, 2026, at 4:00 PM IST. The call was convened to discuss the company's unaudited financial results for the second quarter and the first half of the fiscal year 2027, which concluded on September 30, 2026.
The transcript is now available on the company's website at https://indoramaindia.com/pdf/IndoRama-Earnings-Transcript 261026.pdf, adhering to the prescribed timeline for disclosure.
During the call, management, including Chairman and Managing Director Om Prakash Lohia, Executive Director Vishal Lohia, and Chief Commercial and Financial Officer Umesh Kumar Agrawal, provided insights into the company's performance, strategic investments, and market outlook. Key discussions included the company's transition following significant investments in FY23 and FY24, the stabilization and ramp-up of new capacities, and the positive impact of improved utilization and operating efficiencies on profitability in FY25, FY26, and Q2 FY27.
The management highlighted a proposed INR200 crore investment in specialty filament and specialty fiber production at Butibori, expected to commence commercial operations within Calendar Year 2027. This expansion is projected to increase the top line by approximately 15% and EBITDA by 20%, with a payback period of less than two years. Financial performance for Q2 FY27 showed a 10% year-on-year increase in total income to ₹1,344 crore, a 46.4% rise in EBITDA to ₹117.7 crore, and a 201.8% surge in profit after tax to ₹74.1 crore. For H1 FY27, despite a 9.7% decline in total income to ₹2,284 crore, EBITDA increased by 24.9% to ₹225.7 crore, and profit after tax grew by 78.3% to ₹137.8 crore. The company also reported a significant improvement in operating cash flow and a reduction in net debt, which decreased by 23.5% to approximately ₹852 crore as of September 30, 2026.
Discussions also touched upon the competitive landscape, including the impact of Chinese imports and crude oil price movements, with management expressing confidence in passing on costs and maintaining margins. The potential benefits of upcoming domestic PTA capacity and various trade agreements, such as the India-UK FTA, were also elaborated upon, suggesting a positive outlook for the polyester industry and Indo Rama's growth prospects.
What to do with a filing like this
Indo Rama Synthetics (India) Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indo Rama Synthetics (India) Limited. Read the original for the full detail.